The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...

Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

Last year, surgeons in the US carried out the first transplant of a genetically modified pig kidney into a male subject, who ...

New US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he intends to save $1.8 billion per year, ...

Alcon said that its majority stake means that Aurion will have "broader R&D, regulatory, medical ophthalmic, and commercial ...

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for ...

Eli Lilly's direct-to-consumer platform LillyDirect has been expanded to include in-person and telehealth services for people ...

The company ended 2024 with just under $127 million in cash reserves, and nothing in its pipeline beyond the Alzheimer's ...

Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...

“Differently from the US, in Europe most of the reimbursement is managed at the national level, so not at the European Union ...

The UK government is providing £2 million ($2.6 million) in funding to allow digital assessment to be added to a ...

Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for Prader-Willi syndrome (PWS), a rare genetic ...